Title:
DRUG MANAGEMENT METHOD FOR KIT FORMULATION REQUIRING DOSE ADJUSTMENT
Document Type and Number:
WIPO Patent Application WO/2020/036231
Kind Code:
A1
Abstract:
The objective of the invention is to establish a novel kit formulation and a business model using this kit formulation, contributing to a mechanism for reducing the losses due to disposal of excess drugs, and to the suppression and the reduction of healthcare costs. The invention is the kit formulation combining a container housing a diluting or dissolving liquid such as pure water or an infusion, and a packaging container wherein the intended drug is contained, and a computer network-mediated managing method for the kit formulation.
Inventors:
MIYAZAKI FUTOSHI (JP)
ANDO MAMORU (JP)
ANDO MAMORU (JP)
Application Number:
PCT/JP2019/032206
Publication Date:
February 20, 2020
Filing Date:
August 19, 2019
Export Citation:
Assignee:
REGIMEN KIT INC (JP)
International Classes:
A61J3/00; A61J1/05
Domestic Patent References:
| WO2017038959A1 | 2017-03-09 | |||
| WO2017038959A1 | 2017-03-09 |
Foreign References:
| JP2009528866A | 2009-08-13 | |||
| JP2016062573A | 2016-04-25 | |||
| JP2009528866A | 2009-08-13 | |||
| JP2001524353A | 2001-12-04 | |||
| US6037049A | 2000-03-14 | |||
| JP2008539142A | 2008-11-13 | |||
| JP2001299910A | 2001-10-30 | |||
| JP4303900B2 | 2009-07-29 | |||
| JP2009528866A | 2009-08-13 | |||
| JP2016062573A | 2016-04-25 | |||
| JP2003220116A | 2003-08-05 | |||
| JP2001524353A | 2001-12-04 | |||
| JP2008539142A | 2008-11-13 | |||
| JP2001299910A | 2001-10-30 |
Other References:
NAKAYAMAAKISHIBASAKIYUMIKO ET AL.: "Advances in medical equipment for patients undergoing cancer chemotherapy (from the perspective of nutrition therapy", PARENTERAL AND ENTERAL NUTRITION, vol. 28, no. 2, 2013, pages 635 - 644
TERUMO CORPORATION, ROUND-TABLE DISCUSSION TPN THERAPY CONSIDERING MEDICAL SAFETY SPONSOR, March 2013 (2013-03-01)
"What should I do if I do not administer the dosing solution immediately after preparing it?", OPDIVO Q&A
LABORWELFARE: "Proper use of injectable anticancer agents, etc. ''Research for the creation of guidelines for handling residual liquid", FY2017 HEALTH AND WELFARE ADMINISTRATION PROMOTION SURVEY PROJECT SUBSIDY (HEALTH AND LABOR SCIENCE SPECIAL RESEARCH PROJECT, 22 June 2018 (2018-06-22)
TOSHIAKI NAKAYAMASHIBA ASAKI TYUMIKO ET AL.: "Advancement of medical equipment for patients undergoing cancer chemotherapy (from the viewpoint of nutrition therapy", PARENTERAL AND ENTERAL NUTRITION, vol. 28, no. 2, 2013, pages 635 - 644
TERUMO CORPORATION, ROUND-TABLE DISCUSSION TPN THERAPY CONSIDERING FROM MEDICAL SAFETY SPONSOR, March 2013 (2013-03-01)
"Active ingredients of drugs'' means ''active ingredients", AGENCY FOR INSPECTING DRUGS AND MEDICAL DEVICES, article "dose'' of the prescription package insert of the prescription drug published by"
LABEL'S DOSAGE AND ADMINISTRATION
"Drugs@FDA", PMDA, article "Usage Dose"
"FOOD AND DRUG ADMINISTRATION (FDA", PHARMACEUTICALS AND MEDICAL DEVICES AGENCY (PMDA, article "Dosage"
DRUGS@FDA: "Description of mg/kg or mg/m2 etc. in the column of Label of ''Dosage AND ADMINISTRATION", FDA APPLIED DRUG PRODUCTS
TERUMO CORPORATION, ROUND-TABLE DISCUSSION TPN THERAPY CONSIDERING MEDICAL SAFETY SPONSOR, March 2013 (2013-03-01)
"What should I do if I do not administer the dosing solution immediately after preparing it?", OPDIVO Q&A
LABORWELFARE: "Proper use of injectable anticancer agents, etc. ''Research for the creation of guidelines for handling residual liquid", FY2017 HEALTH AND WELFARE ADMINISTRATION PROMOTION SURVEY PROJECT SUBSIDY (HEALTH AND LABOR SCIENCE SPECIAL RESEARCH PROJECT, 22 June 2018 (2018-06-22)
TOSHIAKI NAKAYAMASHIBA ASAKI TYUMIKO ET AL.: "Advancement of medical equipment for patients undergoing cancer chemotherapy (from the viewpoint of nutrition therapy", PARENTERAL AND ENTERAL NUTRITION, vol. 28, no. 2, 2013, pages 635 - 644
TERUMO CORPORATION, ROUND-TABLE DISCUSSION TPN THERAPY CONSIDERING FROM MEDICAL SAFETY SPONSOR, March 2013 (2013-03-01)
"Active ingredients of drugs'' means ''active ingredients", AGENCY FOR INSPECTING DRUGS AND MEDICAL DEVICES, article "dose'' of the prescription package insert of the prescription drug published by"
LABEL'S DOSAGE AND ADMINISTRATION
"Drugs@FDA", PMDA, article "Usage Dose"
"FOOD AND DRUG ADMINISTRATION (FDA", PHARMACEUTICALS AND MEDICAL DEVICES AGENCY (PMDA, article "Dosage"
DRUGS@FDA: "Description of mg/kg or mg/m2 etc. in the column of Label of ''Dosage AND ADMINISTRATION", FDA APPLIED DRUG PRODUCTS
Download PDF: